Susanna M. Nazarian, PhD,MD

About

Physician Fact Sheet 

Video

Bio: 

Dr. Nazarian is a graduate of the Johns Hopkins University School of Medicine. During her training in General Surgery there, she earned her PhD from the Bloomberg School of Public Health in the Graduate Training Program in Clinical Investigation. She is board certified in General Surgery and certified in Breast Surgery by the Society of Surgical Oncology. Dr. Nazarian is also certified in abdominal transplantation by the American Society of Transplant Surgeons - her first career. Dr. Nazarian is a member of the Association for Academic Surgery, the American Society of Breast Surgeons, and serves on the Council of the Metropolitan Philadelphia Chapter of the American College of Surgeons.  

Years in Practice:

9

Hospital Affiliation: 

Thomas Jefferson University Hospital

Conditions:

• Breast Cancer
• Breast Infections & Inflammations
• Breast Lumps
• Hereditary Breast Ovarian Cancer Syndrome
• Inflammatory Breast Cancer
• Lymphedema
• Male Breast Cancer
• Dense Breasts
• High-Risk Lesions

Treatments: 

• Axillary Lymph Node Dissection
• Lumpectomy
• Mastectomy
• Nipple Sparing Mastectomy
• Transgender Top Surgery 

Areas of Interest: 

• Abnormal mammogram
• Breast cancer risk assessment counseling & monitoring
• Breast conservation surgery
• Cancer care during pregnancy
• Clinical trials/Investigation of clinically-driven research questions
• Dense breasts
• Genetic and familial predisposition to breast cancer/high risk patients
• Gynecomastia/Male breast cancer patients
• High risk breast lesions
• Inflammatory breast cancer
• Lymph node surgery/Sentinel lymph node biopsy
• Lymphedema
• Nipple sparing mastectomy
• Oncoplastic surgery
• SAVI-localized surgery
• Skin sparing mastectomy
• Young women with breast cancer
• LGBTQ+ care

Publications: 

Kidney transplantation and donation in the transgender population: A single-institution case series

Is there an association between body mass index and 21-gene recurrence score?

Impact of 21-Gene Expression Assay on Clinical Outcomes in Node-Negative ≤ T1b Breast Cancer

Refining the indications for neoadjuvant chemotherapy for patients with HER2+ breast cancer: A single institution experience

An Advanced Practice Practitioner–Based Program to Reduce 30- and 90-Day Readmissions After Liver Transplantation

Inpatient pain medication administration: understanding the process and its delays

Twelve-month outcomes after transplant of hepatitis C–infected kidneys into uninfected recipients a single-group trial

Invited Letter Re: The kidney allocation system and its implications for pediatric recipients

Safety and Feasibility of Outpatient Rabbit Antithymocyte Globulin Induction Therapy Administration in Kidney Transplant Recipients

The kidney allocation system does not appropriately stratify risk of pediatric donor kidneys: Implications for pediatric recipients

Pregnancy-induced sensitization promotes sex disparity in living donor kidney transplantation

Comparing outcomes between antibody induction therapies in kidney transplantation

Trial of transplantation of HCV-infected kidneys into uninfected recipients

Insights from a ten-year, prospective study of live kidney donors

Risk factors for nonplatelet thromboxane generation after coronary artery bypass graft surgery

Surgical management of early and late ureteral complications after renal transplantation: Techniques and outcomes

Optimal immunosuppression for HIV-positive kidney transplants: Long-term randomized controlled trials needed

Histologic phenotype on 1-year posttransplantation biopsy and allograft survival in HLA-incompatible kidney transplants

Time course of pathologic changes in kidney allografts of positive crossmatch HLA-incompatible transplant recipients

Eculizumab prevents recurrent antiphospholipid antibody syndrome and enables successful renal transplantation